Welcome to LookChem.com Sign In|Join Free
  • or
(E)-ethyl 3-(5-chloro-2-methoxyphenyl)acrylate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

105475-30-7

Post Buying Request

105475-30-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

105475-30-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 105475-30-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,5,4,7 and 5 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 105475-30:
(8*1)+(7*0)+(6*5)+(5*4)+(4*7)+(3*5)+(2*3)+(1*0)=107
107 % 10 = 7
So 105475-30-7 is a valid CAS Registry Number.

105475-30-7Relevant academic research and scientific papers

Air-stable solid aryl and heteroaryl organozinc pivalates: Syntheses and applications in organic synthesis

Manolikakes, Sophia M.,Ellwart, Mario,Stathakis, Christos I.,Knochel, Paul

, p. 12289 - 12297 (2015/03/31)

A wide range of air-stable, solid, polyfunctional aryl and heteroarylzinc pivalates were efficiently prepared by either magnesium insertion or Hal/Mg exchange followed by transmetalation with Zn(OPiv)2 (OPiv=pivalate). By reducing the amount of

Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives, processes for their preparation, their use, and pharmaceutical preparations comprising them

-

, (2008/06/13)

The present invention relates to cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives of formula I in which A(1), A(2), A(3), R(1), R(2), R(3), R(4), X, Y, and Z have the meanings indicated in the claims. Compounds of formula I are valuable pharmaceutical active compounds which exhibit, for example, an inhibitory action on ATP-sensitive potassium channels in the cardiac muscle and/or in the cardiac nerve and are suitable, for example, for the treatment of disorders of the cardiovascular system such as coronary heart disease, arrhythmias, cardiac insufficiency or cardiomyopathies, or for the prevention of sudden cardiac death, or for improving decreased contractility of the heart. The invention furthermore relates to processes for the preparation of compounds of formula I, their use, and pharmaceutical preparations comprising them.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 105475-30-7